The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Zepbound is the first medication approved to treat patients with obstructive sleep apnea ... 1 drugs Ozempic and Wegovy, this class of medications has become wildly popular as weight-loss and ...

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

So it makes sense that weight loss drugs like Eli LIlly’s Zepbound are being explored as alternatives to traditional obstructive sleep apnea therapies. Dr. Glickman echoes this insight ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.